What companies are 4172.TWO's competitors?

InnoPharmax Inc. (4172.TWO)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does 4172.TWO compare to its peers?

The peer comparison table on this page shows InnoPharmax Inc. (4172.TWO) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does 4172.TWO operate in?

InnoPharmax Inc. (4172.TWO) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

4172.TWO

InnoPharmax Inc.

TWO·Drug Manufacturers, Specialty & Generic · Healthcare

NT$11.20NT$0.10+0.90%

Market capNT$1.32B·Aug 26 6:57 AM UTC

Frequently Asked Questions About 4172.TWO

What companies are 4172.TWO's competitors?: InnoPharmax Inc. (4172.TWO)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does 4172.TWO compare to its peers?: The peer comparison table on this page shows InnoPharmax Inc. (4172.TWO) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does 4172.TWO operate in?: InnoPharmax Inc. (4172.TWO) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

4172.TWO

InnoPharmax Inc.

TWO·Drug Manufacturers, Specialty & Generic · Healthcare

NT$11.20NT$0.10+0.90%

Market capNT$1.32B·Aug 26 6:57 AM UTC

Peers


3054.TW	LIWANLI Innovation Co., Ltd.	NT$54.50	NT$4.4B
1762.TW	Chunghwa Chemical Synthesis & Biotech Co., Ltd.	NT$35.95	NT$2.8B
1780.TWO	Allied Biotech Corporation	NT$24.85	NT$2.7B
6676.TWO	Sunny Pharmtech Inc.	NT$12.35	NT$2.1B
8432.TWO	TSH Biopharm Corporation Limited	NT$50.60	NT$1.9B
6709.TWO	Advagene Biopharma Co., Ltd.	NT$25.85	NT$1.8B
6130.TWO	Shangya Technology Co., Ltd.	NT$27.20	NT$1.3B
1796.TWO	GeneFerm Biotechnology Co., Ltd.	NT$29.05	NT$1.2B
6817.TWO	Winston Medical Supply Co., Ltd.	NT$46.90	NT$863.8M
4132.TWO	Golden Biotechnology Corporation	NT$3.47	NT$632.3M

Frequently Asked Questions About 4172.TWO

What companies are 4172.TWO's competitors?: InnoPharmax Inc. (4172.TWO)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does 4172.TWO compare to its peers?: The peer comparison table on this page shows InnoPharmax Inc. (4172.TWO) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does 4172.TWO operate in?: InnoPharmax Inc. (4172.TWO) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.